NIH-funded research R01 grant

Understanding how HIV persists in brain cells

Official title: Defining the HIV reservoir and latency mechanism in human brain myeloid cells

Funded at Univ of North Carolina Chapel Hill · NIH-11084526 · Data updated 2026-11-12

This study is looking at how certain brain cells in people with HIV might help the virus stay hidden in the body, even when they're on treatment, and it hopes to find new ways to improve care for those living with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMay 6, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$623,736
NIH project number5R01MH136852-02
Project IDNIH-11084526 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are currently on antiretroviral therapy.

Less likely to help

Patients who are not living with HIV or those who are not on antiretroviral therapy may not benefit from this research.

What this research studies

This research investigates the role of human brain myeloid cells in harboring HIV, which may contribute to persistent infection in the central nervous system. By utilizing a unique platform that isolates and expands these brain cells from individuals living with HIV on antiretroviral therapy, the study aims to characterize the mechanisms of HIV latency. The research employs advanced bioinformatics and in vitro infection models to explore how HIV interacts with these cells and the potential for targeted therapies. This work could lead to new insights into HIV reservoirs and improve treatment strategies for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments that target HIV reservoirs in the brain, potentially improving outcomes for individuals living with HIV.

How similar studies have gone: While there has been significant research on HIV latency, this approach focusing specifically on human brain myeloid cells is relatively novel and has not been extensively tested.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Jiang, Guochun — Univ of North Carolina Chapel Hill
  • Study coordinator: Jiang, Guochun

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.